BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11672873)

  • 1. Biodegradable scleral plugs for vitreoretinal drug delivery.
    Yasukawa T; Kimura H; Tabata Y; Ogura Y
    Adv Drug Deliv Rev; 2001 Oct; 52(1):25-36. PubMed ID: 11672873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable microspheres for vitreoretinal drug delivery.
    Herrero-Vanrell R; Refojo MF
    Adv Drug Deliv Rev; 2001 Oct; 52(1):5-16. PubMed ID: 11672871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis.
    Sakurai E; Matsuda Y; Ozeki H; Kunou N; Nakajima K; Ogura Y
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2043-8. PubMed ID: 11481270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits.
    Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
    Curr Eye Res; 1997 Jul; 16(7):633-9. PubMed ID: 9222079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleral plug of biodegradable polymers for controlled drug release in the vitreous.
    Hashizoe M; Ogura Y; Kimura H; Moritera T; Honda Y; Kyo M; Hyon SH; Ikada Y
    Arch Ophthalmol; 1994 Oct; 112(10):1380-4. PubMed ID: 7945044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy.
    Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
    Curr Eye Res; 1995 Jun; 14(6):473-7. PubMed ID: 7671629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
    Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus.
    Veloso AA; Zhu Q; Herrero-Vanrell R; Refojo MF
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):665-75. PubMed ID: 9071221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and Evaluation of Biodegradable Scleral Plug Containing Curcumin in Rabbit Eye.
    Zhang J; Sun H; Zhou N; Zhang B; Ma J
    Curr Eye Res; 2017 Dec; 42(12):1597-1603. PubMed ID: 29111828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular sustained drug delivery using implantable polymeric devices.
    Yasukawa T; Ogura Y; Sakurai E; Tabata Y; Kimura H
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2033-46. PubMed ID: 16263193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release of ganciclovir and foscarnet from biodegradable scleral plugs for the treatment of cytomegalovirus retinitis.
    Peng YJ; Wen CW; Chiou SH; Liu SJ
    Biomaterials; 2010 Mar; 31(7):1773-9. PubMed ID: 19969344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal drug delivery system of all-trans retinoic acid.
    Dong X; Chen N; Xie L; Wang S
    Retina; 2006 Feb; 26(2):210-3. PubMed ID: 16467680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery from ocular implants.
    Yasukawa T; Ogura Y; Kimura H; Sakurai E; Tabata Y
    Expert Opin Drug Deliv; 2006 Mar; 3(2):261-73. PubMed ID: 16506952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
    Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
    Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone--an in vivo study.
    Peng YJ; Kau YC; Wen CW; Liu KS; Liu SJ
    J Biomed Mater Res A; 2010 Aug; 94(2):426-32. PubMed ID: 20186737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery.
    Chowdhury DK; Mitra AK
    Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porous biodegradable microparticles for delivery of pentamidine.
    Mandal TK; Bostanian LA; Graves RA; Chapman SR; Idodo TU
    Eur J Pharm Biopharm; 2001 Jul; 52(1):91-6. PubMed ID: 11438428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil.
    Rubsamen PE; Davis PA; Hernandez E; O'Grady GE; Cousins SW
    Arch Ophthalmol; 1994 Mar; 112(3):407-13. PubMed ID: 8129669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis.
    Kunou N; Ogura Y; Yasukawa T; Kimura H; Miyamoto H; Honda Y; Ikada Y
    J Control Release; 2000 Aug; 68(2):263-71. PubMed ID: 10925134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.